Abstract

These examination concentrated on constructing pharmacosomes accompanying telmisartan to improve allure solubility, bioavailability, and weaken toxicity. Utilizing soya phosphatidylcholine in variable percentages, the complex was qualified by way of financially sound dissolution. The advanced expression (F1, 1:1 percentage) completed a drug aggregation of 96.83% w/w. Description through Radioactivity powder dissemination rooted complex establishment, while leafing through power microscopy revealed plate-formed pieces. In artificial death studies, F1 announced 94.69% of the drug over ten hours, distinguished to 60.42% for clean telmisartan. These verdicts plan that the phospholipid complex considerably upgrades telmisartan's solubility and healing potential.